403 related articles for article (PubMed ID: 18669512)
1. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database.
Nestor SM; Rupsingh R; Borrie M; Smith M; Accomazzi V; Wells JL; Fogarty J; Bartha R;
Brain; 2008 Sep; 131(Pt 9):2443-54. PubMed ID: 18669512
[TBL] [Abstract][Full Text] [Related]
2. Volume changes in Alzheimer's disease and mild cognitive impairment: cognitive associations.
Evans MC; Barnes J; Nielsen C; Kim LG; Clegg SL; Blair M; Leung KK; Douiri A; Boyes RG; Ourselin S; Fox NC;
Eur Radiol; 2010 Mar; 20(3):674-82. PubMed ID: 19760240
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD.
Jack CR; Shiung MM; Gunter JL; O'Brien PC; Weigand SD; Knopman DS; Boeve BF; Ivnik RJ; Smith GE; Cha RH; Tangalos EG; Petersen RC
Neurology; 2004 Feb; 62(4):591-600. PubMed ID: 14981176
[TBL] [Abstract][Full Text] [Related]
4. Mapping correlations between ventricular expansion and CSF amyloid and tau biomarkers in 240 subjects with Alzheimer's disease, mild cognitive impairment and elderly controls.
Chou YY; Leporé N; Avedissian C; Madsen SK; Parikshak N; Hua X; Shaw LM; Trojanowski JQ; Weiner MW; Toga AW; Thompson PM;
Neuroimage; 2009 Jun; 46(2):394-410. PubMed ID: 19236926
[TBL] [Abstract][Full Text] [Related]
5. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
[TBL] [Abstract][Full Text] [Related]
6. A parameter-efficient deep learning approach to predict conversion from mild cognitive impairment to Alzheimer's disease.
Spasov S; Passamonti L; Duggento A; Liò P; Toschi N;
Neuroimage; 2019 Apr; 189():276-287. PubMed ID: 30654174
[TBL] [Abstract][Full Text] [Related]
7. Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration.
Leung KK; Bartlett JW; Barnes J; Manning EN; Ourselin S; Fox NC;
Neurology; 2013 Feb; 80(7):648-54. PubMed ID: 23303849
[TBL] [Abstract][Full Text] [Related]
8. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
9. Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.
Okonkwo OC; Alosco ML; Jerskey BA; Sweet LH; Ott BR; Tremont G;
Alzheimers Dement; 2010 Sep; 6(5):404-11. PubMed ID: 20813341
[TBL] [Abstract][Full Text] [Related]
10. Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimer's disease-related regions.
Lee GJ; Lu PH; Hua X; Lee S; Wu S; Nguyen K; Teng E; Leow AD; Jack CR; Toga AW; Weiner MW; Bartzokis G; Thompson PM;
Biol Psychiatry; 2012 May; 71(9):814-21. PubMed ID: 22322105
[TBL] [Abstract][Full Text] [Related]
11. Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry.
Shi J; Stonnington CM; Thompson PM; Chen K; Gutman B; Reschke C; Baxter LC; Reiman EM; Caselli RJ; Wang Y;
Neuroimage; 2015 Jan; 104():1-20. PubMed ID: 25285374
[TBL] [Abstract][Full Text] [Related]
12. The National Institute on Aging-Alzheimer's Association research criteria for mild cognitive impairment due to Alzheimer's disease: predicting the outcome.
Guo LH; Alexopoulos P; Eisele T; Wagenpfeil S; Kurz A; Perneczky R
Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):325-33. PubMed ID: 22932720
[TBL] [Abstract][Full Text] [Related]
13. White matter signal abnormality quality differentiates mild cognitive impairment that converts to Alzheimer's disease from nonconverters.
Lindemer ER; Salat DH; Smith EE; Nguyen K; Fischl B; Greve DN;
Neurobiol Aging; 2015 Sep; 36(9):2447-57. PubMed ID: 26095760
[TBL] [Abstract][Full Text] [Related]
14. Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: an MRI study of 676 AD, MCI, and normal subjects.
Hua X; Leow AD; Parikshak N; Lee S; Chiang MC; Toga AW; Jack CR; Weiner MW; Thompson PM;
Neuroimage; 2008 Nov; 43(3):458-69. PubMed ID: 18691658
[TBL] [Abstract][Full Text] [Related]
15. Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers.
Dukart J; Sambataro F; Bertolino A
J Alzheimers Dis; 2016; 49(4):1143-59. PubMed ID: 26599054
[TBL] [Abstract][Full Text] [Related]
16. Monitoring disease progression in mild cognitive impairment: Associations between atrophy patterns, cognition, APOE and amyloid.
Falahati F; Ferreira D; Muehlboeck JS; Eriksdotter M; Simmons A; Wahlund LO; Westman E
Neuroimage Clin; 2017; 16():418-428. PubMed ID: 28879083
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's Disease Assessment Scale-Cognitive subscale variants in mild cognitive impairment and mild Alzheimer's disease: change over time and the effect of enrichment strategies.
Podhorna J; Krahnke T; Shear M; Harrison JE;
Alzheimers Res Ther; 2016 Feb; 8():8. PubMed ID: 26868820
[TBL] [Abstract][Full Text] [Related]
18. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer's disease but not in healthy control subjects.
Smith GE; Bohac DL; Waring SC; Kokmen E; Tangalos EG; Ivnik RJ; Petersen RC
Neurology; 1998 Feb; 50(2):355-62. PubMed ID: 9484353
[TBL] [Abstract][Full Text] [Related]
20. From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
Bessi V; Mazzeo S; Padiglioni S; Piccini C; Nacmias B; Sorbi S; Bracco L
J Alzheimers Dis; 2018; 63(4):1523-1535. PubMed ID: 29782316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
